Cited by 1,097Schizophrenia research and treatmentPsychometric Methodologies and TestingMental Health and Psychiatry

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning

Morosini, P.L., Magliano, L., Brambilla, L., Ugolini, S., Pioli, R.·2000·Acta Psychiatrica Scandinavica

DOI 10.1034/j.1600-0447.2000.101004323.x

Open this paper in CoChat — free account

Abstract

Morosini P‐L, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning. Acta Psychiatr Scand 2000: 101:323–329. © Munksgaard 2000. Objective: Development of a scale to assess patients' social functioning, the Personal and Social Performance scale (PSP). Method: PSP has been developed through focus groups and reliability studies on the basis of the social functioning component of the DSM‐TV Social and Occupational Functioning Assessment Scale (SOFAS). The last reliability study was carried out by 39 workers with different professional roles on a sample of 61 psychiatric patients admitted to the rehabilitation unit. Each patient was rated independently on the scale by the two workers who knew them best. Results: The PSP is a 100–point single‐item rating scale, subdivided into 10 equal intervals. The ratings are based mainly on the assessment of patient's functioning in four main areas: 1) socially useful activities; 2) personal and social relationships; 3) self‐care; and 4) disturbing and aggressive behaviours. Operational criteria to rate the levels of disabilities have been defined for the above‐mentioned areas. Excellent inter‐rater reliability was also obtained in less educated workers. Conclusion: Compared to SOFAS, PSP has better face validity and psychometric properties. It was found to be an acceptable, quick and valid measure of patients' personal and social functioning.

Integrity signals

Registry

Crossref · 10.1034/j.1600-0447.2000.101004323.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
Diagnostic and Statistical Manual of Mental Disorders
Sciacca, F., Sharma, R., & Knipe, H. (2020) · Radiopaedia.org · doi:10.53347/rid-80880 · Cited by 2,395
Health Measurement Scales: A Practical Guide To Their Development And Use
Streiner, D. L., & Norman, G. R. (2003) · doi:10.1093/oso/9780198528470.001.0001 · Cited by 1,460
Revising axis V for DSM-IV: a review of measures of social functioning
Goldman, H. H., Skodol, A. E., & Lave, T. R. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1148 · Cited by 1,408
A quality of life interview for the chronically mentally ill
Lehman, A. F. (1988) · Evaluation and Program Planning · doi:10.1016/0149-7189(88)90033-x · Cited by 1,085
A Brief Mental Health Outcome Scale
Jones, S. H., Thornicroft, G., Coffey, M., & Dunn, G. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.5.654 · Cited by 1,019
Burden on the families of patients with schizophrenia: results of the BIOMED I study
Magliano, L., Fadden, G., Madianos, M. G., Caldas‐de‐Almeida, J. M., Held, T., Guarneri, M., Marasco, C., Tosini, P., & Maj, M. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050073 · Cited by 308
Self-citation
Dr. Goldman Replies
GOLDMAN, M. J. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1119-a · Cited by 285
Evidence for limited validity of the revised global assessment of functioning scale
Roy‐Byrne, P., Dagadakis, C. S., Unützer, J., & Ries, R. R. (1996) · Psychiatric Services · doi:10.1176/ps.47.8.864 · Cited by 106

Show all 12 references

Research works printed but not linked: 7

Morosini PL, 1988, Disabiliti sociale e carico familiare: studio di riproducibilità di un nuovo strumento di valutazione, Riv Speriment Fren, 112, 541
Morosini PL, 1991, Routine assessment tools in psychiatry: a questionnaire on family attitudes and burden, Ital J Psychiatr Behav Sci, 1, 95
Magliano L, 1993, Studio di riproducibilità di un' intervista semi‐strutturata per l'accertamento della disabilità sociale e del carico familiare (ADC), Riv Riabilitaz Psichiatr Psicosoc, 2, 49
Morosini PL, 1998, VADO — Valu tazione di Abilita, Definizione di Obiettivi
Moroslini PL, 1996, Prima validazione ed applicazione di uno strumento clinico‐epidemiologico per valutare gli esiti nella riabilitazione psichiatrica: DI. SA, Disabilita e Salute, Riv Speriment Fren, 5, 817
1992, Stata — Statistics/graphics/data management
1997, SPSS — Statistical Package for Social Sciences

Sorted by citations

Items 201–300 of 1,003

Culturally-adapted Family Intervention (CaFI) for African-Caribbeans diagnosed with schizophrenia and their families: a feasibility study protocol of implementation and acceptability
Edge, D., Degnan, A., Cotterill, S., Berry, K., Drake, R., Baker, J. A., Barrowclough, C., Hughes-Morley, A., Grey, P., Bhugra, D., et al. (2016) · Pilot and Feasibility Studies · doi:10.1186/s40814-016-0070-2 · Cited by 40
PSP-Skala – Deutsche Version der Personal and Social Performance Scale
Schaub, D., & Juckel, G. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-3204-4 · Cited by 39
Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia
Jelastopulu, E., Giourou, E., Μερεκούλιας, Γ., Mestousi, A., Moratis, E., & Alexopoulos, E. C. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-197 · Cited by 39
A preliminary exploration of predictors of outcome and cognitive mechanisms of change in cognitive behaviour therapy for psychosis in people not taking antipsychotic medication
Morrison, A. P., Turkington, D., Wardle, M., Spencer, H. M., Barratt, S., Dudley, R. E. J., Brabban, A., & Hutton, P. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.12.001 · Cited by 40
Functioning mediates help-seeking for mental problems in the general population
Michel, C., Schnyder, N., Schmidt, S. J., Groth, N., SCHIMMELMANN, B. G., & Schultze‐Lutter, F. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.06.009 · Cited by 39
Neurovegetative symptom subtypes in young people with major depressive disorder and their structural brain correlates
Toenders, Y. J., Schmaal, L., Harrison, B. J., Dinga, R., Berk, M., & Davey, C. G. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0787-9 · Cited by 39
Small Words That Matter: Linguistic Style and Conceptual Disorganization in Untreated First-Episode Schizophrenia
Silva, A., Limongi, R., Mackinley, M., & Palaniyappan, L. K. (2021) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgab010 · Cited by 42
A longitudinal study of the effects of problematic smartphone use on social functioning among people with schizophrenia: Mediating roles for sleep quality and self-stigma
Chang, K., Chang, Y., Yen, C., Chen, J., Chen, P., Lin, C., Griffiths, M. D., Potenza, M. N., & Pakpour, A. H. (2022) · Journal of Behavioral Addictions · doi:10.1556/2006.2022.00012 · Cited by 41
Altered volume and lateralization of language-related regions in first-episode schizophrenia
Sheng, J., Zhu, Y., Lu, Z., Liu, N., Huang, N., Zhang, Z., Tan, L., Li, C., & Yu, X. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.021 · Cited by 39
A prospective flexible-dose study of paliperidone palmitate in nonacute but symptomatic patients with schizophrenia previously unsuccessfully treated with oral antipsychotic agents.
Schreiner, A., Bergmans, P., Cherubin, P., Keim, S., Rancāns, E., Bez, Y., Parellada, E., Carpiniello, B., Vidailhet, P., & Hargarter, L. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.08.014 · Cited by 42
Paliperidone Extended‐Release for the Treatment of Schizophrenia
Marino, J., & Caballero, J. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.10.1283 · Cited by 38
Social Cognitive Interventions in Neuropsychiatric Patients: A Meta-Analysis
Roelofs, R. L., Wingbermühle, E., Egger, J. I. M., & Kessels, R. P. C. (2016) · Brain Impairment · doi:10.1017/brimp.2016.31 · Cited by 39
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
Huhn, M., Leucht, C., Rothe, P., Dold, M., Heres, S., Bornschein, S., Schneider-Axmann, T., Hasan, A., & Leucht, S. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01109-y · Cited by 38
Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia
Karadayı, G., Emiroğlu, B., & Üçok, A. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.11.012 · Cited by 38
A six month randomized controlled trial of long acting injectable risperidone 50 and 100 mg in treatment resistant schizophrenia
Meltzer, H. Y., Lindenmayer, J., Kwentus, J., Share, D. B., Johnson, R., & Jayathilake, K. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.015 · Cited by 38
Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants
Wykes, T., Stringer, D., Boadu, J., Tinch‐Taylor, R., Csipke, E., Cella, M., Pickles, A. R., McCrone, P., Reeder, C., Birchwood, M. J., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac214 · Cited by 37
Respiration pattern variability and related default mode network connectivity are altered in remitted depression
Zamoscik, V., Schmidt, S. N. L., Gerchen, M. F., Samsouris, C., Timm, C., Kuehner, C., & Kirsch, P. (2018) · Psychological Medicine · doi:10.1017/s0033291717003890 · Cited by 38
Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT
Gumley, A. I., Bradstreet, S., Ainsworth, J. D., Allan, S., Álvarez‐Jiménez, M., Birchwood, M. J., Briggs, A. H., Bucci, S., Cotton, S., Engel, L., et al. (2022) · Health Technology Assessment · doi:10.3310/hlze0479 · Cited by 41
Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
Chue, P. S. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2007.3.1.13 · Cited by 37
Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost–effectiveness
Keith, S. J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.1.9 · Cited by 36
People living with psychosocial disability: Rehabilitation and recovery-informed service provision within the second Australian national survey of psychosis
Harvey, C. A., Brophy, L. M., Parsons, S., Moeller‐Saxone, K., Grigg, M., & Siskind, D. J. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415610437 · Cited by 36
Aberrant spontaneous neural activity and correlation with evoked-brain potentials in first-episode, treatment-naïve patients with deficit and non-deficit schizophrenia
Li, Z., Lei, W., Deng, W., Zheng, Z., Li, M., Ma, X., Wang, Q., Huang, C., Li, N., Collier, D. A., et al. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.01.001 · Cited by 36
Antidepressive response of inpatients with major depression to adjuvant occupational therapy: a case–control study
Edel, M., Blackwell, B., Schaub, M., Emons, B., Fox, T., Tornau, F., Vieten, B., Roser, P., Haussleiter, I. S., & Juckel, G. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-016-0124-0 · Cited by 36
Deep brain stimulation for severe treatment-resistant obsessive-compulsive disorder: An open-label case series
Farrand, S., Evans, A. H., Mangelsdorf, S., Loi, S. M., Mocellin, R., Borham, A., Bevilacqua, J., Blair‐West, S., Walterfang, M., Bittar, R. G., et al. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417731819 · Cited by 36
Home visits in the Danish High Risk and Resilience Study – VIA 7: assessment of the home environment of 508 7‐year‐old children born to parents diagnosed with schizophrenia or bipolar disorder
Gantriis, D. L., Thorup, A. A. E., Harder, S. K., Greve, A. N., Henriksen, M. T., Zahle, K. K., Stadsgaard, H., Ellersgaard, D., Burton, B. K., Christiani, C. J., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13057 · Cited by 36
A cross-sectional examination of the clinical significance of autistic traits in individuals experiencing a first episode of psychosis
Chisholm, K., Pelton, M., Duncan, N., Kidd, K., Wardenaar, K. J., Upthegrove, R., Broome, M. R., Lin, A. P., & Wood, S. J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112623 · Cited by 38
Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study
Bioque, M., Parellada, E., García‐Rizo, C., Amoretti, S., Fortea, A., Oriolo, G., Palau, P., Boix-Quintana, E., Safont, G., & Bernardo, M. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.72 · Cited by 36
Implementation, efficacy, costs and processes of inpatient equivalent home-treatment in German mental health care (AKtiV): protocol of a mixed-method, participatory, quasi-experimental trial
Baumgardt, J., Schwarz, J., Bechdolf, A., Nikolaidis, K., Heinze, M., Hamann, J., Holzke, M., Längle, G., Richter, J., Brieger, P., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03163-9 · Cited by 38
How are we assessing functioning in schizophrenia? A need for a consensus approach
Peuskens, J., & Gorwood, P. A. P. M. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.013 · Cited by 36
Resilience Predicts Self-Stigma and Stigma Resistance in Stabilized Patients With Bipolar I Disorder
Post, F., Buchta, M., Kemmler, G., Pardeller, S., Frajo-Apor, B., & Hofer, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.678807 · Cited by 35
Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol
Baandrup, L., Fagerlund, B., Jennum, P., Lublin, H., Hansen, J. L., Winkel, P., Gluud, C. N., Oranje, B., & Glenthoj, B. Y. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-160 · Cited by 35
Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk
Lemmers-Jansen, I. L. J., Fett, A.-K. J., Hanssen, E., Veltman, D. J., & Krabbendam, L. (2018) · Psychological Medicine · doi:10.1017/s003329171800140x · Cited by 37
Age-Related Reduction in Cortical Thickness in First-Episode Treatment-Naïve Patients with Schizophrenia
Lin, Y., Li, M., Zhou, Y., Deng, W., Ma, X., Wang, Q., Guo, W., Li, Y., Jiang, L., Hu, X., et al. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00348-x · Cited by 34
Clinical and functional ultra-long-term outcome of patients with a clinical high risk (CHR) for psychosis
Beck, K., Studerus, E., Andreou, C., Egloff, L., Leanza, L., Simon, A. E., Borgwardt, S., & Riecher‐Rössler, A. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2019.08.005 · Cited by 35
Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states
Glenthøj, L. B., Kristensen, T. D., Wenneberg, C., Hjorthøj, C. R., & Nordentoft, M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.01.012 · Cited by 40
Elementary sensory deficits in schizophrenia indexed by impaired visual mismatch negativity
Farkas, K., Stefanics, G., Marosi, C., & Csukly, G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.05.011 · Cited by 35
Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
Marder, S. R., Hakala, M., Josiassen, M. K., Zhang, P. G. Y., Ouyang, J., Weiller, E., Weiss, C., & Hobart, M. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.57 · Cited by 35
Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Huang, M., Yang, T., Ten, P.-R., Su, P., Wu, B., Chan, C.-H., Lan, T., Liu, I., Chiu, W., Li, C., et al. (2012) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-12-1 · Cited by 34
Prognostic and prescriptive predictors of improvement in a naturalistic study on inpatient and day hospital treatment of depression
Zeeck, A., von Wietersheim, J., Weiß, H., Scheidt, C. E., Völker, A., Helesic, A., Eckhardt‐Henn, A., Beutel, M. E., Endorf, K., Treiber, F., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.039 · Cited by 34
A Randomized Controlled Trial on the Efficacy of a Psychosocial Behavioral Intervention to Improve the Lifestyle of Patients With Severe Mental Disorders: Study Protocol
Sampogna, G., Fiorillo, A., Luciano, M., Vecchio, V. D., Steardo, L., Pocai, B., Barone, M., Amore, M., Pacitti, F., Dell’Osso, L., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00235 · Cited by 36
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia
DeMartinis, N. A., Lopez, R. N., Pickering, E. H., Schmidt, C. J., Gertsik, L., Walling, D. P., & Ogden, A. G. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001047 · Cited by 34
Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial
Glenthøj, L. B., Mariegaard, L. S., Fagerlund, B., Jepsen, J. R. M., Kristensen, T. D., Wenneberg, C., Krakauer, K., Medalia, A. A., Roberts, D. L., Hjorthøj, C. R., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.08.016 · Cited by 37
A comparison of thought and perception disorders in borderline personality disorder and schizophrenia: psychotic experiences as a reaction to impaired social functioning
Oliva, F., Dalmotto, M., Pirfo, E., Furlan, P. M., & Picci, R. L. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0239-2 · Cited by 34
Assessing Feasibility and Acceptability of Web-Based Enhanced Relapse Prevention for Bipolar Disorder (ERPonline): A Randomized Controlled Trial
Lobban, F. A., Dodd, A., Sawczuk, A. P., Asar, Ö., Dagnan, D., Diggle, P. J., Griffiths, M., Honary, M., Knowles, D., Long, R., et al. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7008 · Cited by 34
Patient, family and provider views of measurement-based care in an early-psychosis intervention programme
Cuperfain, A. B., Hui, K., Berkhout, S., Foussias, G., Gratzer, D., Kidd, S. A., Kozloff, N., Kurdyak, P. A., Linaksita, B., Miranda, D., et al. (2021) · BJPsych Open · doi:10.1192/bjo.2021.1005 · Cited by 33
A systematic review of social functioning outcome measures in schizophrenia with a focus on suitability for intervention research
Long, M., Stansfeld, J. L., Davies, N., Crellin, N. E., & Moncrieff, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.02.011 · Cited by 33
Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients
Bejerot, S., Sigra, S., Henriksson, E. W., Eklund, D., Hylén, U., & Humble, M. B. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.12.003 · Cited by 33
Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia
Fowler, J. A., Bettinger, T. L., & Argo, T. R. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.02.011 · Cited by 33
The Impact of Insight on Functioning in Patients With Schizophrenia or Schizoaffective Disorder Receiving Risperidone Long-Acting Injectable
Gharabawi, G. M., Bossie, C. A., Turkoz, I., Kujawa, M. J., Mahmoud, R. A., & Simpson, G. M. (2007) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31815c1982 · Cited by 33
Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: Interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets
Patrick, D. L., Burns, T., Morosini, P., Gagnon, D. D., Rothman, M., & Adriaenssen, I. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.02.003 · Cited by 32
Self-citation
Adjunctive armodafinil for negative symptoms in adults with schizophrenia: A double-blind, placebo-controlled study
Kane, J. M., Yang, R., & Youakim, J. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.006 · Cited by 32
A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia
Hirayasu, Y., Sato, S., Takahashi, H., Iida, S., Shuto, N., Yoshida, S., Funatogawa, T., Yamada, T., & Higuchi, T. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0778-9 · Cited by 32
Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis
Glenthøj, L. B., Jepsen, J. R. M., Hjorthøj, C. R., Bak, N. K., Kristensen, T. D., Wenneberg, C., Krakauer, K., Nordentoft, M., & Fagerlund, B. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12682 · Cited by 34
Sex Differences in Verbal Memory Predict Functioning Through Negative Symptoms in Early Psychosis
Buck, G., Lavigne, K. M., Makowski, C., Joober, R., MALLA, A. K., & Lepage, M. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa054 · Cited by 32
Triple network hypothesis-related disrupted connections in schizophrenia: A spectral dynamic causal modeling analysis with functional magnetic resonance imaging
Xi, Y., Guo, F., Liu, W., Fu, Y., Li, J., Wang, H., Chen, F., Cui, L., Zhu, Y., Li, C., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.06.024 · Cited by 35
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study
Dollfus, S., Mucci, A., Giordano, G. M., Bitter, I., Austin, S. F., Delouche, C., Erfurth, A., Fleischhacker, W. W., Movina, L. G., Glenthoj, B. Y., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.826465 · Cited by 32
Cognitive impairment in schizophrenia: the great unmet need
Aquila, R., & Citrome, L. (2015) · CNS Spectrums · doi:10.1017/s109285291500070x · Cited by 32
Trauma-focused therapy in early psychosis: results of a feasibility randomized controlled trial of EMDR for psychosis (EMDRp) in early intervention settings
Varese, F., Sellwood, W., Pulford, D., Awenat, Y. F., Bird, L., Bhutani, G., Carter, L., Davies, L. M., Aseem, S., Davis, C., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723002532 · Cited by 32
Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
Macfadden, W., DeSouza, C., Crivera, C., Kozma, C. M., Dirani, R. D., Mao, L., & Rodriguez, S. C. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-167 · Cited by 31
Feasibility and acceptability of an exergame intervention for schizophrenia
Campos, C., Mesquita, F., Marques, A. J., Trigueiro, M. J., Orvalho, V., & Rocha, N. (2015) · Psychology of sport and exercise · doi:10.1016/j.psychsport.2015.02.005 · Cited by 31
Bipolar II disorder in patients with a current diagnosis of recurrent depression
Mosolov, S. N., Ushkalova, A., Kostukova, E. G., Shafarenko, A., Alfimov, P., Борисовна, К. А., & Angst, J. (2014) · Bipolar Disorders · doi:10.1111/bdi.12192 · Cited by 32
Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia
Hargarter, L., Bergmans, P., Chérubin, P., Keim, S., Conca, A., Serrano‐Blanco, A., Bitter, I., Bilanakis, N., & Schreiner, A. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1174692 · Cited by 31
Monitoring and predicting the risk of violence in residential facilities. No difference between patients with history or with no history of violence
de Girolamo, G., Buizza, C., Sisti, D., Ferrari, C., Bulgari, V., Iozzino, L., Boero, M. E., Cristiano, G., Francesco, A. D., Giobbio, G. M., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.05.010 · Cited by 31
Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis
Siskind, D. J., Harris, M., Phillipou, A., Morgan, V. A., Waterreus, A. J., Galletly, C. A., Carr, V. J., Harvey, C. A., & Castle, D. J. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000305 · Cited by 31
A systematic review of clinician-rated instruments to assess adults’ levels of functioning in specialised public sector mental health services
Burgess, P. M., Harris, M., Coombs, T., & Pirkis, J. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416688098 · Cited by 31
Clinical and functional characteristics of young adults living in single room occupancy housing: preliminary findings from a 10-year longitudinal study
Barbic, S. P., Jones, A. A., Woodward, M., Piercy, M., Mathias, S., Vila-Rodriguez, F., Leonova, O., Smith, G. N., Buchanan, T., Vertinsky, A. T., et al. (2018) · Canadian Journal of Public Health · doi:10.17269/s41997-018-0087-9 · Cited by 26
Taking others into account: combining directly experienced and indirect information in schizophrenia
Simonsen, A., Fusaroli, R., Petersen, M. L., Vermillet, A., Bliksted, V., Mors, O. N., Roepstorff, A., & Campbell-Meiklejohn, D. K. (2021) · Brain · doi:10.1093/brain/awab065 · Cited by 27
Improving physical activity and diet in patients with severe mental disorders: Results from the LIFESTYLE multicentric, real-world randomized controlled trial
Luciano, M., Sampogna, G., Amore, M., Bertolino, A., Dell’Osso, L., Rossi, A., Siracusano, A., Calcagno, P., Carmassi, C., Lorenzo, G. D., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114818 · Cited by 35
Beyond dopamine: Novel strategies for schizophrenia treatment
Dudzik, P., Lustyk, K., & Pytka, K. (2024) · Medicinal Research Reviews · doi:10.1002/med.22042 · Cited by 33
Nonverbal expressive behaviour in schizophrenia and social phobia
Del-Monte, J., Raffard, S., Salesse, R. N., Marín, L., Schmidt, R. C., Varlet, M., Bardy, B. G., Boulenger, J., Gély-Nargeot, M. C., & Capdevielle, D. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.05.034 · Cited by 30
Stepped Care as an Implementation and Service Delivery Model for Cognitive Behavioral Therapy for Psychosis
Kopelovich, S. L., Strachan, E. D., Sivec, H. J., & Kreider, V. A. L. (2019) · Community Mental Health Journal · doi:10.1007/s10597-018-00365-6 · Cited by 31
The brief negative symptom scale in translation: A review of psychometric properties and beyond
Tatsumi, K., Kirkpatrick, B. W., Strauss, G. P., & Opler, M. G. A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.018 · Cited by 30
A Feasibility and Acceptability Trial of Social Cognitive Therapy in Early Psychosis Delivered Through a Virtual World: The VEEP Study
Thompson, A. D., Elahi, F., Realpe, A. X., Birchwood, M. J., Taylor, D., Vlaev, I., Leahy, F., & Bucci, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00219 · Cited by 30
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia
Correll, C. U., Ismail, Z., McIntyre, R. S., Rafeyan, R., & Thase, M. E. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.lu21112ah2 · Cited by 30
Assessing PTSD-related Functional Impairment and Quality of Life
Holowka, D. W., & Marx, B. P. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195399066.013.0021 · Cited by 29
Personal and social functioning in schizophrenia: defining a clinically meaningful measure of maintenance in relapse prevention
Nicholl, D., Nasrallah, H. A., Nuamah, I. F., Akhras, K. S., Gagnon, D. D., & Gopal, S. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003798927 · Cited by 29
EEG correlates of face recognition in patients with schizophrenia spectrum disorders: A systematic review
Murashko, A. A., & Shmukler, A. B. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.03.027 · Cited by 29
Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
Hříbková, H., Svoboda, O., Bartečků, E., Zelinková, J., Hořínková, J., Lacinová, Ľ., Piskáček, M., Lipový, B., Provazník, I., Glover, J. C., et al. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.830757 · Cited by 33
Patterns of care in patients discharged from acute psychiatric inpatient facilities
The PROGRES-Acute Group, Preti, A., Rucci, P., Gigantesco, A., Santone, G., Picardi, A., Miglio, R., & de Girolamo, G. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0498-2 · Cited by 29
Long-stay in short-stay inpatient facilities: risk factors and barriers to discharge
Gigantesco, A., de Girolamo, G., Santone, G., Miglio, R., Picardi, A., & the PROGRES-Acute group (2009) · BMC Public Health · doi:10.1186/1471-2458-9-306 · Cited by 29
An Asian study on clinical and psychological factors associated with personal recovery in people with psychosis
Lim, M., Li, Z., Xie, H., Tan, B. L., & Lee, J. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2238-9 · Cited by 28
Poverty and inequality in real-world schizophrenia: a national study
Fond, G. B., Yon, D. K., Tran, B. X., Mallet, J., Urbach, M., Leignier, S., Rey, R., Misdrahi, D., Llorca, P., Schürhoff, F., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1182441 · Cited by 28
Subtyping schizophrenia: A comparison of positive/negative and system-specific approaches
Lang, F. U., Walther, S., Stegmayer, K., Anderson‐Schmidt, H., Schulze, T. G., Becker, T. M., & Jäger, M. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.05.014 · Cited by 28
Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder
Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Weisinger, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.11.011 · Cited by 27
A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).
Takeuchi, H., Fervaha, G., Lee, J., Agid, O., & Remington, G. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.06.005 · Cited by 27
A psychological intervention for suicide applied to non-affective psychosis: the CARMS (Cognitive AppRoaches to coMbatting Suicidality) randomised controlled trial protocol
Gooding, P. A., Pratt, D., Awenat, Y. F., Drake, R., Elliott, R. A., Emsley, R., Huggett, C., Jones, S. H., Kapur, N., Lobban, F. A., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02697-8 · Cited by 29
Aerobic endurance training to improve cognition and enhance recovery in schizophrenia: design and methodology of a multicenter randomized controlled trial
Maurus, I., Hasan, A., Schmitt, A., Roeh, A., Keeser, D., Malchow, B., Schneider-Axmann, T., Hellmich, M., Schmied, S., Lembeck, M., et al. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01175-2 · Cited by 26
Acute conceptual disorganization in untreated first-episode psychosis: a combined magnetic resonance spectroscopy and diffusion imaging study of the cingulum
Pan, Y., Dempster, K., Jeon, P., Théberge, J., Khan, A. R., & Palaniyappan, L. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200167 · Cited by 28
Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia
Citrome, L., Du, Y., Risinger, R. C., Stankovic, S., Claxton, A., Zummo, J., Bose, A., Silverman, B. L., & Ehrich, E. W. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000106 · Cited by 28
High-Yield Cognitive Behavioral Techniques for Psychosis Delivered by Case Managers to Their Clients With Persistent Psychotic Symptoms
Turkington, D., Munetz, M. R., Pelton, J., Montesano, V. L., Sivec, H. J., Nausheen, B., & Kingdon, D. (2013) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000070 · Cited by 29
Patterns of service utilisation in psychosis: Findings of the 2010 Australian National Survey of Psychosis
Raudino, A., Carr, V. J., Bush, R. A. B., Saw, S., Burgess, P. M., & Morgan, V. A. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413511996 · Cited by 28
A randomised controlled trial of recovery focused CBT for individuals with early bipolar disorder
Jones, S. H., Mulligan, L. D., Law, H., Dunn, G., Welford, M., Smith, G. M., & Morrison, A. P. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-204 · Cited by 31
Course of illness in a sample of patients diagnosed with a schizotypal disorder and treated in a specialized early intervention setting. Findings from the 3.5 year follow-up of the OPUS II study
Albert, N., Glenthøj, L. B., Melau, M., Jensen, H., Hjorthøj, C. R., & Nordentoft, M. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.013 · Cited by 28
Violent behaviour in early psychosis patients: Can we identify clinical risk profiles?
Moulin, V., Palix, J., Golay, P., Dumais, A., Gholam‐Rezaee, M., Azzola, A., Baumann, P., Alameda, L., & Conus, P. (2017) · Early Intervention in Psychiatry · doi:10.1111/eip.12512 · Cited by 28
Outcome measurement in chronic mental illness
Trauer, T. (2010) · International Review of Psychiatry · doi:10.3109/09540261003667525 · Cited by 26
Cognitive functioning following discontinuation of antipsychotic medication. A naturalistic sub-group analysis from the OPUS II trial
Albert, N., Randers, L., Allott, K., Jensen, H., Melau, M., Hjorthøj, C. R., & Nordentoft, M. (2018) · Psychological Medicine · doi:10.1017/s0033291718001836 · Cited by 28
Measuring social and occupational functioning of people with bipolar disorder: A systematic review
Akers, N., Lobban, F. A., Hilton, C., Panagaki, K., & Jones, S. H. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2019.101782 · Cited by 27
Neurocognitive functions in persistent negative symptoms following a first episode of psychosis
Lepage, M., Bodnar, M. D., Raucher‐Chéné, D., Lavigne, K. M., Makowski, C., Joober, R., & MALLA, A. K. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.02.008 · Cited by 25
The impact of clinical and social factors on the physical health of people with severe mental illness: Results from an Italian multicentre study
Luciano, M., Sampogna, G., Vecchio, V. D., Giallonardo, V., Palummo, C., Andriola, I., Amore, M., Rossi, R., Carmassi, C., Siracusano, A., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114073 · Cited by 31
Association between exposome score for schizophrenia and functioning in first-episode psychosis: results from the Athens first-episode psychosis research study
Erzın, G., Pries, L.-K., Dimitrakopoulos, S., Ralli, I., Xenaki, L.-A., Soldatos, R. F., Vlachos, I., Selakovic, M., Foteli, S., Kosteletos, I., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721004542 · Cited by 27

Authors: Morosini, P. L., Magliano, L., Brambilla, L., Ugolini, S., & Pioli, R.
Corresponding author: Morosini, P.L.
ORCID: Magliano, L.
Venue: Acta Psychiatrica Scandinavica
Publisher: Wiley
Published: 2000-04
Volume: 101
Issue: 4
Pages: 323-329
ISSN: 0001-690X (ISSN-L)
1600-0447
DOI: 10.1034/j.1600-0447.2000.101004323.x
OpenAlex: W4244847179
Cited by: 1,097
References: 12
Citations by year: 2026: 30 · 2025: 47 · 2024: 40 · 2023: 70 · 2022: 100 · 2021: 86 · 2020: 154 · 2019: 80 · 2018: 77 · 2017: 57 · 2016: 73 · 2015: 56 · 2014: 44 · 2013: 47 · 2012: 32
FWCI: 0.23
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 632 d)
Locations: Acta Psychiatrica Scandinavica (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: SOFA, occupational functioning, psychometric validation, reliability statistics, acceptability, DSM-IV, psychiatric assessment instruments

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks